International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

van Huizen A. M., Menting S. P., Gyulai R., Iversen L., van der Kraaij G. E., Middelkamp-Hup M. A., ...More

JAMA DERMATOLOGY, vol.158, no.5, pp.561-572, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 158 Issue: 5
  • Publication Date: 2022
  • Doi Number: 10.1001/jamadermatol.2022.0434
  • Journal Name: JAMA DERMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, DIALNET
  • Page Numbers: pp.561-572
  • Akdeniz University Affiliated: No


IMPORTANCE A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen could potentially optimize the treatment of patients with psoriasis worldwide.